← Back to Clinical Trials
Recruiting NCT07674836

NCT07674836 SPSIP Block Versus ESP Block for Chronic Pain After Unilateral Breast Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07674836
Status Recruiting
Phase —
Sponsor Engin Çetin
Condition Postoperative Pain
Study Type INTERVENTIONAL
Enrollment 90 participants
Start Date 2026-07-01
Primary Completion 2026-12-01

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Serratus Posterior Superior Intercostal Plane BlockUltrasound-guided Erector Spinae Plane Block

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 90 participants in total. It began in 2026-07-01 with a primary completion date of 2026-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This prospective, randomized, assessor-blinded study will compare serratus posterior superior intercostal plane block and erector spinae plane block in adult female patients undergoing unilateral breast surgery. The primary outcome is chronic postoperative pain at 3 months, assessed using the Brief Pain Inventory-Short Form.

Eligibility Criteria

Inclusion Criteria: * Female patients aged 18-65 years * ASA physical status I-III * Body mass index (BMI) between 18 and 35 kg/m² * Scheduled for elective unilateral breast surgery (mastectomy with or without sentinel lymph node biopsy) * Ability to understand and provide written informed consent Exclusion Criteria: * Infection at the site of block application * Known allergy to local anesthetics * Coagulopathy or anticoagulant therapy * Chronic opioid use * Pregnancy * Inability to communicate or cooperate * Refusal to participate * Failed block * Requirement of additional intraoperative analgesia outside the study protocol * Development of serious intraoperative complications

Contact & Investigator

Central Contact

Engin Çetin, M.D.

✉ Doccetin52@gmail.com

📞 05321206004

Principal Investigator

Engin Çetin, M.D

PRINCIPAL INVESTIGATOR

Kocaeli City Hospital

Frequently Asked Questions

Who can join the NCT07674836 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 65 Years, studying Postoperative Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07674836 currently recruiting?

Yes, NCT07674836 is actively recruiting participants. Contact the research team at Doccetin52@gmail.com for enrollment information.

Where is the NCT07674836 trial being conducted?

This trial is being conducted at İzmit, Turkey (Türkiye).

Who is sponsoring the NCT07674836 clinical trial?

NCT07674836 is sponsored by Engin Çetin. The principal investigator is Engin Çetin, M.D at Kocaeli City Hospital. The trial plans to enroll 90 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology